ALOX5 and medium chain acyl-CoA dehydrogenase deficiency: Besides its function as leukotriene receptor antagonist montelukast was, in addition, shown to exhibit some 5-LOX-inhibiting potential [56,57], which might further aid in controlling pLT release in MCAD patients.